InsiderTrades.com logo
"Doomsday indicator” flashing for the first time since the Great Depression...
From Behind the Markets   |   Ad
It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...
Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>

OBIO Insider Trading

Insider Ownership Percentage: 6.70%
Insider Buying (Last 12 Months): $49,550.00
Insider Selling (Last 12 Months): $138,572.97

Orchestra BioMed Insider Trading History Chart

This chart shows the insider buying and selling history at Orchestra BioMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Orchestra BioMed Share Price & Price History

Current Price: $5.11
Price Change: ▼ Price Decrease of -0.71 (-12.20%)
As of 09/16/2024 03:38 PM ET

This chart shows the closing price history over time for OBIO up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
BREAKING NEWS: AI Tech Now Used to Stop School Shooters
From Market JAR   |   Ad
Two seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a shooter's exact location.
Don't miss out. Get the full details on this AI bargain.

Orchestra BioMed Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/9/2024Darren ShermanInsiderSell6,804$5.48$37,285.92772,691View SEC Filing Icon  
9/9/2024Eric S FainDirectorSell1,800$5.43$9,774.0043,010View SEC Filing Icon  
9/6/2024Darren ShermanInsiderSell6,819$5.65$38,527.35779,495View SEC Filing Icon  
9/6/2024Eric S FainDirectorSell2,000$5.64$11,280.0044,810View SEC Filing Icon  
9/4/2024Darren ShermanInsiderSell6,837$6.10$41,705.70793,275View SEC Filing Icon  
8/14/2024David P HochmanInsiderBuy2,500$5.84$14,600.00567,998View SEC Filing Icon  
6/25/2024David P HochmanInsiderBuy1,000$6.95$6,950.00333,502View SEC Filing Icon  
5/30/2024William Reed LittleInsiderBuy4,000$7.00$28,000.00307,859View SEC Filing Icon  
See Full Table
"Doomsday indicator” flashing for the first time since the Great Depression...
From Behind the Markets   |   Ad
It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...
Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>

SEC Filings (Institutional Ownership Changes) for Orchestra BioMed (NASDAQ:OBIO)

53.55% of Orchestra BioMed stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at OBIO by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Orchestra BioMed Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/16/2024SkyView Investment Advisors LLC20,000$0.16M0.0%N/A0.056%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company 42,082$0.34M0.0%+8.4%0.118%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers26,439$0.22M0.0%+192.7%0.074%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp70,682$0.58M0.0%+115.7%0.197%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD571,075$3.01M0.0%-8.3%1.596%Search for SEC Filing on Google Icon
5/11/2024Catalytic Wealth RIA LLC22,261$0.12M0.0%N/A0.062%Search for SEC Filing on Google Icon
2/1/2024New York State Common Retirement Fund3,623$33K0.0%-68.6%0.010%Search for SEC Filing on Google Icon
10/27/2023Allspring Global Investments Holdings LLC4,904$43K0.0%N/A0.014%Search for SEC Filing on Google Icon
10/27/2023TD Asset Management Inc92,678$0.81M0.0%+100.0%0.259%Search for SEC Filing on Google Icon
10/24/2023Bank of New York Mellon Corp40,290$0.35M0.0%+211.2%0.113%Search for SEC Filing on Google Icon
10/18/2023UMB Bank n.a.3,160$28K0.0%N/A0.009%Search for SEC Filing on Google Icon
10/13/2023Arkadios Wealth Advisors51,595$0.45M0.0%N/A0.144%Search for SEC Filing on Google Icon
8/24/2023Perceptive Advisors LLC2,052,868$14.37M0.4%-9.9%5.744%Search for SEC Filing on Google Icon
8/11/2023Atika Capital Management LLC64,651$0.45M0.0%N/A0.181%Search for SEC Filing on Google Icon
5/16/2023Boxer Capital LLC250,000$4.89M0.2%N/A2.230%Search for SEC Filing on Google Icon
5/15/2023RTW Investments LP5,118,507$100.17M2.1%N/A45.652%Search for SEC Filing on Google Icon
4/18/2023IFP Advisors Inc2,980$34K0.0%N/A0.027%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Orchestra BioMed logo
Orchestra BioMed Holdings, Inc. operates as a biomedical innovation company. The company's flagship product candidates include BackBeat Cardiac Neuromodulation Therapy (CNT) for the treatment of hypertension (HTN); and Virtue Sirolimus AngioInfusion Balloon (SAB) for the treatment of atherosclerotic artery disease. Its products also comprise FreeHold devices and minimally invasive surgery devices. The company has a collaboration agreement with Medtronic, Inc. for the development and commercialization of BackBeat CNT for the treatment of HTN in patients indicated for a cardiac pacemaker; and a strategic collaboration with Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral artery disease. Orchestra BioMed Holdings, Inc. is based in New Hope, Pennsylvania.
Read More on Orchestra BioMed

Today's Range

Now: $5.11
Low: $4.48
High: $5.56

50 Day Range

MA: $6.81
Low: $5.51
High: $8.64

52 Week Range

Now: $5.11
Low: $4.22
High: $11.69

Volume

306,916 shs

Average Volume

80,964 shs

Market Capitalization

$182.88 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.44

Who are the company insiders with the largest holdings of Orchestra BioMed?

Orchestra BioMed's top insider investors include:
  1. Darren Sherman (Insider)
  2. David P Hochman (Insider)
  3. William Reed Little (Insider)
  4. Eric S Fain (Director)
Learn More about top insider investors at Orchestra BioMed.

Who are the major institutional investors of Orchestra BioMed?

Orchestra BioMed's top institutional investors include:
  1. Bank of New York Mellon Corp — 0.20%
  2. The Manufacturers Life Insurance Company — 0.12%
  3. Rhumbline Advisers — 0.07%
  4. SkyView Investment Advisors LLC — 0.06%
Learn More about top institutional investors of Orchestra BioMed stock.

Which major investors are buying Orchestra BioMed stock?

In the last quarter, OBIO stock was bought by institutional investors including:
  1. Bank of New York Mellon Corp
  2. SkyView Investment Advisors LLC
  3. Rhumbline Advisers
  4. The Manufacturers Life Insurance Company
During the previous year, these company insiders have bought Orchestra BioMed stock:
  1. Darren Sherman (Insider)
  2. David P Hochman (Insider)
Learn More investors buying Orchestra BioMed stock.
"Doomsday indicator” flashing for the first time since the Great Depression...
From Behind the Markets   |   Ad
It's been a bloodbath in the markets. The seven most valuable US tech companies lost a combined $1 trillion - in a single day. And things could get a lot worse...
Click here to discover how Wall Street insiders are quietly preparing for a market crash >>>